Daily Stock List
Catalyst Copper Corp. (CCY.V)
Today we are reporting on Catalyst Copper Corp. (CCY.V), here at the QualityStocks Daily Newsletter.
Listed on the TSX Venture Exchange, Catalyst Copper Corp. engages in the acquisition, exploration, and development of mineral properties, mainy copper and base metals in Mexico. The Company formerly went by the name SVIT Gold Corp. They changed their name to Catalyst Copper Corp. in January of 2010. The Company is based in Vancouver, British Columbia.
Catalyst Copper's current focus is the La Verde copper property. This property is in the Sierra Madre del Sur approximately 320 kilometers west of Mexico City in Michoacán State. Michoacán is rich in natural resources as well as agriculturally diverse. Mining is a leading industry in the state, with sizeable production of gold, silver, zinc, iron and copper.
La Verde consists of two claims, Capire and Unificación Santa Maria, consisting of approximately 16,900 hectares. Copper mineralization was first identified on the Sierra del Marqués (the intrusive now called La Verde) in the early 1900s.
The La Verde copper porphyry mineralization has undergone exploration since the 1970s. This has resulted in the discovery of two mineralized copper zones: East Hill and West Hill. La Verde has an exposed porphyry copper system amenable to open pit mining with two known zones of porphyry style copper ± gold ± molybdenum mineralization.
In April, Catalyst Copper announced that, further to their Press Release dated March 4, 2013, Catalyst and their wholly owned Mexican subsidiary, Minera Hill 29 S.A. de C.V., entered into a Purchase Option Agreement dated April 9, 2013 with certain subsidiaries of Teck Resources Ltd. Catalyst has an option to acquire indirectly Teck's interest in the La Verde property, subject to TSX-V approval.
The La Verde property is in an area with excellent infrastructure - power, rail and water. Major upside potential remains for the two known zones of porphyry style copper, gold and silver mineralization as drill programs have shown both deposits remain open to depth and along strike.
Catalyst Copper Corp. (CCY.V), closed Thursday's session at $0.04, even for the day, on 15,000 volume. The stock's 52-week low/high is $0.04/$0.09.
Hondo Minerals Corp. (HMNC)
OtcWizard and FeedBlitz reported previously on Hondo Minerals Corp. (HMNC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTC Markets' OTCQB, Hondo Minerals Corp. engages in the acquisition of mines, mining claims and mining real estate in the U.S., Canada, and Mexico, with mineral reserves consisting of precious metals or non-ferrous metals. Since early 2010, Hondo has been constructing and developing a plant designed to process precious and base metals in the Tennessee and Schuylkill Mines in the Wallapai Mining District near Chloride, Mohave County, Arizona. This property is the host of what once was the largest producer of silver in Arizona history. Hondo Minerals has their corporate headquarters in Addison, Texas.
The Company's primary focus is the processing of the tailings pile at the mouth of the Tennessee Mine. This includes approximately a one million ton tailings pile containing different amounts of lead, zinc, gold, silver, and other concentrations of metal. This is next to the Schuylkill Mine. Hondo Minerals also owns assorted mining claims in Colorado and Utah. However, none is operational as of January 31, 2013. Hondo owns 540 acres of mineral rights and an additional 720 acres of minerals claimed.
Early independent testing has shown the Tennessee Mine has approximately a million tons of tailings and dump material. These can produce commercial amounts of gold and silver using the Company's exclusive technology above ground. The Tennessee Mine has as much as 40 percent of the historically proven veins intact underground. Therefore, Hondo believes the Tennessee Mine offers long-range opportunities for continued growth through its underground reserves. The Tennessee Mine operated from the late 1800s until 1947; it produced lead, zinc, gold as well as silver.
Today, Hondo Minerals announced that the Company entered into a binding Letter of Intent (LOI) with Crowncorp Investments Corp., a Texas corporation, for the sale of 100 percent of Hondo Minerals' assets and issued and outstanding stock for a purchase price of $88 million. This includes $13 million in working capital to be retained in the Company post-closing.
Hondo Minerals Corp. (HMNC), closed Thursday's trading session at $0.193, up 103.16%, on 2,515,587 volume with 300 trades. The average volume for the last 60 days is 238,133 and the stock's 52-week low/high is $0.05/$0.41.
Northumberland Resources, Inc. (NHUR)
Today we are reporting on Northumberland Resources, Inc. (NHUR), at the QualityStocks Daily Newsletter.
Incorporated in 2009, Northumberland Resources, Inc. engages in the business of oil and gas exploration and production. Their plan of operation is to further develop their oil and gas acquisitions in Kansas and carry out further exploration and acquisition in the oil and gas sectors. The Company has upgraded the facilities on their acquired Mason, Thompson, Keyes and Harrell Sanders, Asmussen and Carver leases with the goal of improving current oil and gas production. Northumberland Resources has their corporate headquarters in Las Vegas, Nevada.
As of November 1, 2012, Company Management has consolidated their Operational Management under Lasso Energy, LLC. Northumberland has committed up to $250,000 in a joint venture program with partner and Operator, Lasso Energy to update the Sawyer Field and develop additional production from this major asset.
The Company's oil and gas projects are in the Mississippi Lime region in southern Kansas. Currently, Northumberland Resources has 13 oil and gas producing leases with 19 producing wells and 7 salt-water disposal wells (SWD).
They also hold interests in 6 undeveloped oil and gas leases consisting of 1215 acres of prime leaseholds scheduled for future development. Northumberland commenced production in 2011. The shallow, high-permeability, high-porosity, oil- and gas-liquids-rich Mississippi Lime lies beneath approximately 6.5 million acres in northern Oklahoma and southern Kansas.
At the end of October 2012, Northumberland Resources announced that they received and accepted an offer to purchase 100 percent of their 30 percent working interest in their Lester lease, 15 percent interest in their Miller lease and 20 percent interest in their Moon leases for $384,686 as part of their 2013 expansion plans.
They will use the funds to expand the current oil production on their 5 lease Sawyer oil and gas field, develop current leases and acquire additional proven producing properties. In addition, they will be participating in new production drilling on their current interests on the Carver, Asmussen and Holt leases.
Northumberland Resources, Inc. (NHUR), closed at $1.02, up 7.37%, on 827,525 volume with 466 trades. The average volume for the last 60 days is 73,853 and the stock's 52-week low/high is $0.24/$0.97.
Polar Petroleum Corp. (POLR)
Dividend Opportunities, Trade of the Week, Insider Wealth Alert, and Oakshire Financial reported this week on Polar Petroleum Corp. (POLR), FeedBlitz did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Polar Petroleum Corp. is an independent American oil and gas company whose shares trade on the OTCQB. The Company is focusing on securing domestic energy solutions through the exploration, development and production of oil and natural gas in Alaska's proven North Slope region. Polar Petroleum's projects include Franklin Bluffs and Hemi Springs. The Company has their headquarters in Anchorage, Alaska.
Polar Petroleum's Franklin Bluffs Project overlies the three source rocks thought to represent potential unconventional shale oil on the North Slope. Test drilling in the vicinity has met expectations for finding oil in the source rocks (Petroleum News, Sept. 23, 2012). The Company holds the rights to the 5,701-acres (8.91-square miles) onshore Franklin Bluffs Project. Polar Petroleum has acquired a 100 percent working interest in the project's single lease. They've assigned a 4 percent carried interest to the seller.
Their Hemi Springs Project is estimated to potentially represent recoverable petroleum reserves of approximately 558 million barrels of oil (Geologic Study and Initial Evaluation of the Potential Petroleum Reserves of the Hemi Springs Project, North Slope, Alaska (D. T. Gross & D. W. Brizzolara, Mar. 25, 2013).
According to the Study, the Hemi Springs Project area carries significant hydrocarbon potential. This is mainly because of its unique position in close association with two of North America's largest oil and gas accumulations, the Prudhoe Bay Field and the Kuparuk River Field. The Hemi Springs Project is on the southern boundary of the Prudhoe Bay Unit and southeast of the Kuparuk River Unit. Together, these constitute the majority of the oil production on the North Slope (51 percent and 20 percent, respectively).
Recently, Polar Petroleum announced the appointment of Mr. Steven Costa as Engineering Advisor, Mr. Peter Brown as Surveying Advisor, and Mr. David Walker as Logistical Advisor to the Company's Advisory Board. The Company will draw upon the expertise of these advisors as needed as Polar Petroleum moves forward with their plans for the exploration, development and production of oil and gas on their North Slope assets in Alaska.
Polar Petroleum Corp. (POLR), closed Thursday's trading session at $4.09, up 18.90%, on 728,286 volume with 688 trades. The average volume for the last 60 days is 18,821 and the stock's 52-week low/high is $0.0157/$3.50.
Nemaska Lithium, Inc. (NMX.V)
BabyBulls reported previously on Nemaska Lithium, Inc. (NMX.V), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Nemaska Lithium, Inc. is an exploration and development company whose intention is to become a lithium hydroxide/carbonate producer based in Quebec. The Company is concentrating on the development of their 100 percent owned Whabouchi lithium deposit. Nemaska has lithium/berylium properties situated in the James Bay region of Quebec. Nemaska Lithium is also an important shareholder of Monarques Resources, Inc. (MQR.V). Based in Quebec, Nemaska Lithium's shares trade on the TSX Venture Exchange.
The Company has the Whabouchi as well as their Sirmac lithium deposits in Quebec. The Whabouchi lithium deposit is near the Cree community of Nemaska and the Nemiscau airport. The Company's Whabouchi deposit is the second richest deposit in the world. The Whabouchi Property consists of one block totaling 33 claims covering an area of 1,761.9 ha. The claims are 100 percent-owned by Nemaska Lithium. The Sirmac Property consists of 15 claims covering a total area of 645 ha.
The Company has filed patent applications for their proprietary method to produce lithium hydroxide and lithium carbonate. Nemaska intends to build a Phase I lithium hydroxide plant using their proprietary chemical transformation process. Their lithium hydroxide/carbonate processing plant will be in Salaberry-de-Valleyfield, Quebec. The plant has been designed with the flexibility to produce 27,000 tonnes of lithium hydroxide and 4,000 tonnes of lithium carbonate should the market demand for hydroxide outpace lithium carbonate.
This week, Nemaska Lithium announced that the Company was a first place award winner in the Strategic Investment category at the 6th Gala des sociétés en Bourse 2013 that took place on April 3, 2013. Mr. Gaétan Morin, Vice President Corporate Development and Investment of the Fonds de Solidarité FTQ presented the Strategic Investment Award to Guy Bourassa, President and CEO of Nemaska Lithium.
The award recognizes the importance of investments in infrastructure, R & D or innovation during 2012. The award was given to Nemaska Lithium for their investment in developing an innovative lithium hydroxide production process. The Company has filed for patent protection on a process that produces lithium hydroxide using electrolysis technology.
Today, Nemaska Lithium, Inc. (NMX.V), closed at $0.22, up 4.76%, on 166,700 volume. The stock's 52-week low/high is $0.18/$0.65.
Bourque Industries, Inc. (BORK)
TradingAuthority Daily, StreetAuthority Daily, and TopStockAnalysts reported earlier on Bourque Industries, Inc. (BORK), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Bourque Industries, Inc. is an advanced materials science company that develops and produces metal alloys and related product applications using their cutting-edge Kryron metal-alloying process. Kryronized alloys have shown potential worldwide for paradigm-shifting applications across a wide array of industries. These include ballistic armor, electrical, aviation, automotive, mining, medical devices, agriculture & heavy equipment, consumer electronics, and others. Bourque Industries' shares trade on the OTC Markets' OTC Pink Current Information.
Founded in 20011, the Company has their headquarters in Tucson, Arizona. Bourque is a development stage enterprise. They are in the process of commercializing their patented Kryron metal-alloying process utilizing nanotechnology to alter, fundamentally, common metals at the molecular level to create ultra-high performing super alloys.
Bourque conducts research and development to optimize Kryron alloys for specific applications, produces and manufactures Kryron alloys and specific product applications to the highest quality standards, and develops marketing programs and strategies to penetrate industrial markets around the world with Kryron alloys. Furthermore, they manage strategic partnerships, acquisitions, and product development to provide ancillary or complimentary products, systems and technology to further the use of Kryron alloys and products globally.
The Kryronization process creates Carbon Nanotube Metal Matrix Composites (CNT-MMC) using standard alloys and base metals. Carbon nanotubes (CN) are one-dimensional nanostructures. Because of their unique electrical versatility, they are capable of providing premier electrical and mechanical properties. The Kryronization process solved the problems of providing a reliable and cost-effective process for the uniform dispersion of carbon nanotubes in metal. The resulting CNT-MMC materials have enhanced qualities in terms of heat dissipation, electrical conductivity, hardness and resistance to corrosion.
Bourque Industries announced in February their first LED purchase order for US$252,000 from Shenzhen JBT Electronics Technology Co., Ltd. (JBT) for Kryronized aluminum. This is for use in the LED Heat Sink lighting industry. In JBT Electronics' testing so far, they found that the Kryron metal provided for testing was able to provide sufficient heat dissipation within only 14 square centimeters for each watt of LED power (considering only LED lights of 10 watts or more). This is greater than a 60 percent reduction in the size requirement of heat sinks cooling LED lights, currently. JBT Electronics is a high technology LED company in Guangdong, China.
Bourque Industries, Inc. (BORK), closed at $0.0428, up 7.00%, on 161,300 volume with 6 trades. The average volume for the last 60 days is 606,678 and the stock's 52-week low/high is $0.0082/$0.59.
BlastGard International, Inc. (BLGA)
Today we are highlighting BlastGard International, Inc. (BLGA), here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, BlastGard International, Inc. manufactures and markets proprietary blast mitigation materials through BlastGard International. In addition, the Company designs, manufactures and distributes a unique range of leading security products and personal protective gear through HighCom Security. BlastGard's principal market focus is on blast effects mitigation for the commercial sector, military, law enforcement and government agencies. BlastGard International is based in Clearwater, Florida.
The Company's patented BlastWrap® technology effectively mitigates blast effects and suppresses post-blast fires. BlastWrap® is a concept not a chemical compound; from it, blast protection products are made. This technology can be used to create new, finished products or be used to retrofit to existing products. HighCom Security provides a broad spectrum of security products and personal protective gear, including tactical armor, which are tailored and offer protection solutions to specific customer needs.
BlastWrap® is a very low-density blast effect mitigation material. It can prevent sympathetic detonation, substantially reduce impulse, peak pressure, reflected pressure, quasi-static pressure in partially or fully confined environments and kill after burn and post-blast fires. BlastWrap® has a non-toxic fire and flash suppressant element to deal with the fireball.
The construction of BlastWrap® products are from two flexible films arranged one over the other and joined by a plurality of seams filled with attenuating filler material (volcanic glass bead or other suitable two-phase materials). BlastWrap® is designed for each application with an extinguishing coating that offers an innovative blast protection system against all blast and fire/burn threats.
BlastWrap® can be used to make containers, linings, barriers, walls, as well as barricades. BlastWrap® kits enable one to ship pallets to a remote site for rapid erection and installation, without a requirement for special equipment, skills, materials, or power. BlastWrap® variants can function as Building Materials, Decorative Facings, Linings and Wall Components. BlastWrap® can be wrapped around or fit to any shape.
In April, BlastGard International reported financial results for the year ended December 31, 2012. The Company reported consolidated revenues of $3,496,433 in comparison to $334,209 for the year ended December 31, 2011. Their consolidated gross profit for 2012 was $1,133,208, versus $72,160 for 2011. For 2012, BlastGard had net income from operations of $19,567 in comparison to a loss from operations of $1,718,644 for 2011. For 2012, their net income was $1,044,967 versus a net loss of $3,872,185 for the comparable period of the prior year.
HighCom Security product sales for 2012 of $3,274,137 represented approximately 94 percent of total sales for the year. Most of the remaining sales were for BlastGard's blast mitigating garbage receptacles, the BlastGard MTR.
BlastGard International, Inc. (BLGA), closed Thursday's trading session at $0.039, up 11.43%, on 2,980,110 volume with 257 trades. The average volume for the last 60 days is 43,174 and the stock's 52-week low/high is $0.0036/$0.035.
Axion Power International, Inc. (AXPW)
SmarTrend Newsletters, Profit Confidential, SmallCapVoice, and AllPennyStocks reported previously on Axion Power International, Inc. (AXPW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 2003, Axion Power International, Inc. is the industry leader in the field of lead-acid-carbon energy storage technologies. The Company develops, designs, manufactures and sells advanced energy storage components and devices based on their patented PbC Technology™. The PbC® battery is a hybrid device that uses the standard lead acid battery positive electrode and a supercapacitor negative electrode that is made of activated carbon. Axion Power International lists on the OTC Markets' OTCQB.
Their subsidiary, Axion Power Battery Manufacturing, Inc., conducts the Company's operations at their battery plant located in New Castle, Pennsylvania. Axion's future goal, after filling their plant's lead-carbon battery production capacity, is to become the leading supplier of carbon electrode assemblies for the worldwide lead-acid battery industry.
The Company's PbC® prototypes offer several key performance advantages over conventional lead-acid batteries. These advantages include excellent partial state-of-charge performance, substantially longer life in string applications with minimal battery management, significantly better charge acceptance (10 - 20 times depending on use of the battery), as well as much faster recharge rates. Advantages also include significantly longer cycle lives in deep discharge applications; reduced premature failures and warranty claims and more environmentally friendly (significantly less lead).
Concerning the company's PbC Technology™, the full technical description is a "multi-celled asymmetrically supercapacitive lead-acid-carbon hybrid battery." Like a lead-acid battery, Axion Power's battery consists of a series of cells. However, within the individual cells, their construction is more complex. The negative electrodes in lead-acid batteries are simple sponge lead plates. Axion's negative electrodes are five-layer assemblies that consist of a carbon electrode, a corrosion barrier, a current collector, a second corrosion barrier and a second carbon electrode. They then sandwich together these electrode assemblies with conventional separators and positive electrodes to make their battery. It is filled with an acid electrolyte, sealed, and connected in series to the other cells.
Recently, the Company announced that they completed, and started operating, their new improved continuous roll carbon sheeting line. The carbon sheet is a vital component of Axion's proprietary negative electrode. To date, it has been manufactured by hand utilizing many identical stations to provide enough carbon sheet to satisfy existing PbC® battery production needs. An automated production system was the long established goal; this second generation continuous-roll carbon sheeting production line, when coupled with the Company's robotic negative electrode production line, completely automates the manufacturing process.
This week, Axion Power International announced plans to release their results for First Quarter 2013 before the market opens in New York on Thursday, May 16, 2013. Their management team will host a conference call to discuss the Company's financial results on the same day, at 11:00 am ET.
Axion Power International, Inc. (AXPW), closed Thursday's session at $0.26, down 0.38%, on 184,550 volume with 32 trades. The average volume for the last 60 days is 213,501 and the stock's 52-week low/high is $0.2001/$0.4549.
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.3785, up 0.48%, on 293,785 volume with 41 trades. The stock’s average daily volume over the past 60 days is 66,267, and its 52-week low/high is $0.25/$1.25.
The Aristocrat Group Corp. reported today that as they await final federal approval on the label and bottle design for their new ultra-premium vodka, the company’s brand management division, Luxuria Brands, is already organizing major plans for the American-made spirit’s launch. Talks continue with noted celebrities and highly influential clubs and other venues in major key markets like LA and Las Vegas, with official hosted premiere events celebrating the release of Luxuria’s debut vodka already in the works.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Pushes to Launch New Vodka in Key Markets
U.S. Patent Office Clears ASCC’s New Vodka Brand
ASCC Brings Luxuria Brands to the Silver Screen
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.0945, up 0.53%, on 428,687 volume with 408 trades. The stock’s average daily volume over the past 60 days is 427,416, and its 52-week low/high is $0.0618/$0.28.
Cardium Therapeutics, Inc. announced a major publication today by the company's CSO, Gabor M Rubanyi, M.D., Ph.D., on therapeutic stimulation of mechanistic adaptive coronary collateral growth, the primary target for therapeutic angiogenesis. The publication draws on a decade and a half of Dr. Rubanyi's work in a clinical research environment studying therapeutic angiogenesis using growth factor proteins and genes. The full article is available to all interested parties, just call Cardium at 858-436-1000.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium Announces Generx Publication In Molecular Therapy
Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
Cardium Receives ISO Certification for Excellagen
Low Carbon Technologies International, Inc. (LWCTF)
The QualityStocks Daily Newsletter would like to spotlight Low Carbon Technologies International, Inc. (LWCTF). Today, The Aristocrat Group Corp. closed trading at $0.131, down 6.43%, on 236,995 volume with 15 trades. The stock’s average daily volume over the past 60 days is 205,087, and its 52-week low/high is $0.02/$1.25.
Low Carbon Technologies International, Inc. informed markets today that they will be releasing year-to-date financials for the preceding 6-month period by May 7th. Investors will get a good chance this coming Tuesday to pop the hood on this ingeniously diversified Clean-tech, Construction, Energy & Energy Efficiency, Environmental, Mining and Real Estate pioneer.
Low Carbon Technologies International, Inc. (LWCTF) is a U.S. based diversified clean-tech holding company focused on the clean-tech, construction, energy, environmental, mining, and real estate sectors. The company’s primary focus is on generating consistent shareholder growth by minimizing expenses and increasing asset values through leveraged acquisitions.
In addition to acquiring profitable companies, LWCTF’s business strategy includes the use of its various technologies in the development of clean-tech projects which are generally located on the company’s real estate assets. As an additional source of revenue, LWCTF also issues sub-licenses to third parties in exchange for a fair amount of project equity and licensing royalties.
To date, LWCTF has acquired 20 clean-tech technologies focused on the following segments: biofuels & chemicals, biomass, energy efficiency, energy storage, environmental mitigation bank, green building, LED lighting, solar, solar desalination, transportation, waste-to-energy, and water. According to a third party appraisal by Marshall & Stevens, the company’s technologies are currently valuated at approximately $142 million.
LWCTF’s management team has accumulated extensive experience in the carbon sector and is well supported by a board of directors comprised of individuals with a wealth of knowledge within the company’s primary sectors of clean-tech operations. The business strategy executed by these professionals has been highly profitable with LWCTF on track to generate upwards of $28 million in EBITDA for fiscal 2013. Disclaimer
Low Carbon Technologies International, Inc. Company Blog
Low Carbon Technologies International, Inc. News:
LCTI Low Carbon Technologies International Inc. Plans to Announce 6 Month YTD Financials
LCTI Low Carbon Technologies Poised for Up-Listing; Looks Toward OTCQX Market on Heels of Upcoming Quarterly Financial Disclosure
LCTI Low Carbon Technologies YTD Contracts Exceed Fiscal 2012 Year End Revenues
GNCC Capital, Inc. (GNCP)
The QualityStocks Daily Newsletter would like to spotlight GNCC Capital, Inc. (GNCP). Today, GNCC Capital, Inc. closed trading at $0.0102, on 730,556 volume with 36 trades. The stock’s average daily volume over the past 60 days is 336,938, and its 52-week low/high is $0.0055/$0.09.
GNCC Capital, Inc. reported yesterday on their evaluation of a potential gold exploration property acquisition significantly larger and more developed than any other exploration property in the company's current portfolio, and today is pleased to announce they are very close to closing the deal. While extensive due diligence is yet pending and some deliberations must yet be accomplished, GNCC is now poised to execute on this major asset deal, confident of the long-term fundamental drivers for the gold sector and seeing the recent dip as a huge opportunity.
GNCC Capital, Inc. (GNCP) is a gold and silver exploration company with six different projects, all of which were carefully selected due to their outstanding characteristics. The company’s geologists will supervise an extensive exploration program for these projects to prove up reserves through geological surveys and a substantial number of carefully planned drilling programs.
The company’s initial exploration properties, located in Arizona, consist of Esther Basin, Burnt Well, Clara Gold, Kit Carson, Silverfields, and Potts Mountain. GNCC Capital plans to create significant value for its initial properties portfolio through continued exploration and joint ventures, as well as through acquiring additional gold and silver exploration assets.
GNCC Capital currently holds circa 80% of its assets in gold exploration properties. The strong rise in gold prices over recent years make this company attractive to investors seeking to benefit from the increasing value of precious metals. Backed by a world-class management team with decades of experience in the financial and mining sectors, GNCC Capital is well positioned to capitalize on the upward trend.
The company’s focus is creating value for its shareholders, employees, and business and social partners through responsible and safe exploration, mining, and marketing. While gold exploration is the company’s main focus, GNCC Capital will take advantage of value-creating opportunities in other minerals where it can leverage existing assets, skills, and experience. Disclaimer
GNCC Capital, Inc. Company Blog
GNCC Capital, Inc. News:
GNCC Capital, Inc. to Complete Acquisition
GNCC Capital, Inc. Update on Potential Acquisition
GNCC Capital, Inc. Evaluates Acquisition
Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, today highlighted the publication, “Mechanistic, Technical, and Clinical Perspectives in Therapeutic Stimulation of Coronary Collateral Development by Angiogenic Growth Factors,” authored by Gabor M Rubanyi, M.D., Ph.D., Cardium’s chief scientific officer in the April issue of Molecular Therapy.
The publication frameworks the mechanistic basis of adaptive coronary collateral growth, the biological processes to be targeted by therapeutic angiogenesis, and the optimization of clinical trial designs, including information on designating appropriate clinical trial endpoints, selecting patients who are likely responders to therapeutic stimulation of collateral development, and potential genetic and molecular markers in patient screening.
Dr. Rubanyi also summarizes the knowledge gained in the last 15 years of pre-clinical and clinical research and development initiatives in the field of therapeutic angiogenesis using growth factor proteins and genes.
“I also described in some detail the specific insights that our team, first at Schering AG (now part of Bayer Healthcare) and now at Cardium, has gained in the course of the development of Generx, one of the most advanced therapeutic angiogenesis product candidates,” Dr. Rubanyi stated in the press release. “These lessons have been invaluable and they have been incorporated into the trial design of the Generx ASPIRE pivotal phase 3 clinical study now underway at several leading cardiovascular centers in the Russian Federation.”
Generx is Cardium’s interventional cardiology-focused product candidate currently in development as a non-surgical option for the treatment of a medical condition termed cardiac microvascular insufficiency (CMI).
The abstract of the publication is available at www.nature.com/mt/journal/v21/n4/abs/mt201313a.html (membership required for full viewing). The company will mail the full article to interested parties upon request by contacting Cardium at 858-436-1000.
For more information visit www.cardiumthx.com
The Aristocrat Group Corp. is pushing hard to finalize its launch strategy as it waits for final federal approval on the label and bottle design of its new ultra-premium vodka. Luxuria Brands—the company’s brand management division—is currently in talks with clubs and venues in Las Vegas and Los Angeles about hosting official premiere events celebrating the release of Luxuria’s debut vodka.
“We’re targeting party hotspots in L.A. and Vegas because they’re destinations on the cutting edge of celebrity culture and nightlife,” stated ASCC CEO Robert Federowicz. “Our executive leadership has cultivated relationships with club owners and hospitality managers that can help us put on top-flight premiere events to spread the word about our new liquor products across the country.”
According to today’s press release, ASCC is in active talks with venues suitable for large roll-out events featuring popular DJs and bottle service; exactly the kind of events that attract cultural tastemakers. The company sees the successful debut of its American-made ultra-premium vodka as the foundation of its growing brand management business. U.S. sales of super-premium vodkas, which typically retail around $30 a bottle, have risen 32 percent in the last two years to $1.2 billion, according to industry trade group the Distilled Spirits Council (DISCUS).
For more information, visit www.aristocratgroupcorp.com
Approximately two months ago, GNCC Capital announced that it was evaluating the potential acquisition of a gold exploration property. Notably, this property is significantly larger and more developed than any other exploration property in the company’s present portfolio.
GNCC Capital today told investors that it anticipates completing this acquisition very shortly, following extensive due diligence and deliberations. Completing this acquisition will significantly increase the company’s size and its exposure to the gold sector.
Emphasizing its bullish outlook on gold over the medium and long term, the company reaffirmed its commitment to the gold sector and said it views the recent dip in gold prices as an opportunity. GNCC Capital is solely focused on properties that meet its criteria for low-cost extraction.
This acquisition will be funded through the issuance of a combination of new Preferred Stock in the company and long term loan notes. GNCC Capital remains committed to its long-standing pledge not to issue additional shares of its Common Stock.
Upon completion of this acquisition, GNCC Capital will substantially increase the amount of the existing $1 million credit facility from Diamond Peak and source additional available credit facilities, should it so require.
In other news, GNCC Capital said it is completing a new and updated web site as well as creating a social media platform, as part of a recently initiated plan to boost investor awareness of the company.
For more information, visit www.gncc-capital.com
Stem cell technology has traditionally been associated with therapeutic regeneration, using these basic building blocks of life to generate new cells that can replace damaged cells. Potential therapeutic applications run the gamut from the replacement of damaged nerve cells to the generation of new heart or liver tissue. However, VistaGen Therapeutics, which is in fact involved in researching and developing therapeutic applications, is best known for a totally different but no less important application of stem cell technology.
Stem cells, in addition to therapeutic applications, can allow scientists to generate mature human cells right in the laboratory; cells that can then be used to efficiently screen drugs for possible toxicity without going through the time and expense involved in human clinical trials, and this is just what VistaGen is focused on doing. The company’s proprietary Human Clinical Trials in a Test Tube stem cell based drug assay platform provides a major advantage to anyone involved in the extremely expensive and risky process of new drug development.
In particular, VistaGen plans to use the technology itself to build a pipeline of drug rescue variants, drugs that have important therapeutic potential but have been shelved due to heart or liver toxicity issues. VistaGen is convinced that it can rescue some of these drugs, using their unique in-lab testing system to economically tweak them, maintaining their demonstrated efficacy while removing their toxicity. VistaGen can then enjoy significant economic participation rights as the new drug is taken to market.
Clearly there are also other rich options the company may soon find itself considering. A powerful technology such as this could result in billions of dollars saved, by helping to avoid the massive costs involved in going to market with a fatally flawed new drug, and such a tool, once finalized, could carry huge licensing potential. In addition, VistaGen could easily become a takeover target, as large pharmaceutical companies look for quick ways to fill profit gaps left by expiring patents.
For additional information, visit www.VistaGen.com
Today's Top 3
Center Stage Stocks
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Reports Encouraging Preliminary Data from Penn Phase 1 ADXS-cHER2 Canine Osteosarcoma Study
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Generx Publication In Molecular Therapy
- DoMark International, Inc. (DOMK) Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products
- GNCC Capital, Inc. (GNCP) to Complete Acquisition
- GlobalWise Investments, Inc. (GWIV) Enters Into New Channel Sales Partnership With Muratec America
- International Stem Cell Corp. (ISCO) to Present at American Society of Gene and Cell Therapy 16th Annual Meeting
- Loans4Less.com, Inc. (LFLS) Ranked in List as a Top Residential Loan Originator 2012
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Personalized Medicine Poised to Revolutionize Insurance & Pharmaceuticals
- The Aristocrat Group Corp. (ASCC) Pushes to Launch New Vodka in Key Markets
- The Guitammer Company Inc. (GTMM) Partner Wins Prestigious "ET NOW Leaders of Tomorrow Awards 2012"
- VentriPoint Diagnostics Ltd. (VPTDF) Receives Health Canada License for the NRV(TM) Application for Non-Specific Heart Disease
- Viaspace, Inc. (VSPC) 7 MW Power Purchase Agreement Nearly Finalized in St. Croix, Giant King Grass Growing Well
- VistaGen Therapeutics, Inc. (VSTA) Announces $36 Million Strategic Financing Agreement